Home
Providers
MOMA Therapeutics
MOMA Therapeutics
MOMA Therapeutics is a Cambridge, Massachusetts drug-discovery company founded in 2020 that builds precision medicines against molecular machines — the highly dynamic proteins that convert chemical energy stored in cells into regulatory work such as protein transport, DNA repair and degradation, and whose constant conformational shape-shifting has historically made them undruggable. Its proprietary KNOMATIC platform combines advanced structural frameworks and functional-genomics target validation with high-throughput fragment and DNA-encoded-library screening, CRISPR gene editing, artificial intelligence for detecting dynamic conformational patterns, and machine-learning lead optimisation, all built against a continually expanding structure-function knowledge base. The company launched in April 2020 with an $86 million Series A led by Third Rock Ventures, added a $150 million Series B in May 2022, and has taken two wholly owned oncology assets into the clinic: MOMA-313, a selective inhibitor of the polymerase theta (Polθ) helicase domain for homologous- recombination-deficient tumours, which entered Phase 1 in August 2024; and MOMA-341, a potent and selective WRN helicase inhibitor for microsatellite-unstable and TA-repeat-expanded tumours, which dosed its first Phase 1 patient in July 2025. It also runs a five-year discovery collaboration with Roche announced in January 2024, an oncology collaboration and licence agreement with Bayer signed in October 2024, and an exclusive licence for a selective PARP1 inhibitor announced in January 2025. MOMA Therapeutics runs no developer program and publishes no product API, developer portal, API reference or machine-readable specification. The only machine-readable surface reachable without credentials is the WordPress REST content API behind momatx.com, catalogued here.
MOMA Therapeutics publishes 10 APIs on the APIs.io network, including Content Posts API, Content Pages API, Team API, and 7 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Oncology.
MOMA Therapeutics’ developer surface includes product news, engineering blog, YouTube channel, authentication, and 24 more developer resources.
10 APIs
On this page
Kin Score
APIs 10
Pricing Plans 1
Rate Limits 1
Security Posture 2
Resources 28
apis.yml
0 Operational Transparency
Composite quality — 32.3/100 · thin
Agent readiness — 24/100 · agent aware
Individual APIs this provider publishes, each with its own machine-readable definition.
Scroll for all 10
Published pricing tiers and plan structures.
Documented rate limits and quota policies.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Learn 1
Tutorials, courses, talks, and written guidance
Operate 2
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 8
The organization behind the API
Scroll for all 8
Other 4
Properties that don't map to a standard resource type
Source (apis.yml)
aid: moma-therapeutics
name: MOMA Therapeutics
description: 'MOMA Therapeutics is a Cambridge, Massachusetts drug-discovery company founded in 2020 that builds precision
medicines against molecular machines — the highly dynamic proteins that convert chemical energy stored in cells into regulatory
work such as protein transport, DNA repair and degradation, and whose constant conformational shape-shifting has historically
made them undruggable. Its proprietary KNOMATIC platform combines advanced structural frameworks and functional-genomics
target validation with high-throughput fragment and DNA-encoded-library screening, CRISPR gene editing, artificial intelligence
for detecting dynamic conformational patterns, and machine-learning lead optimisation, all built against a continually expanding
structure-function knowledge base. The company launched in April 2020 with an $86 million Series A led by Third Rock Ventures,
added a $150 million Series B in May 2022, and has taken two wholly owned oncology assets into the clinic: MOMA-313, a selective
inhibitor of the polymerase theta (Polθ) helicase domain for homologous- recombination-deficient tumours, which entered
Phase 1 in August 2024; and MOMA-341, a potent and selective WRN helicase inhibitor for microsatellite-unstable and TA-repeat-expanded
tumours, which dosed its first Phase 1 patient in July 2025. It also runs a five-year discovery collaboration with Roche
announced in January 2024, an oncology collaboration and licence agreement with Bayer signed in October 2024, and an exclusive
licence for a selective PARP1 inhibitor announced in January 2025. MOMA Therapeutics runs no developer program and publishes
no product API, developer portal, API reference or machine-readable specification. The only machine-readable surface reachable
without credentials is the WordPress REST content API behind momatx.com, catalogued here.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: true
label: Hosted service · you call their endpoint
confidence: high
source:
- openapi
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: open
trial: false
try_now: false
public: true
label: Open access
confidence: medium
source:
- authentication
- rate-limits
- security
generated: '2026-09-02'
method: derived
image: https://momatx.com/wp-content/uploads/2025/03/logo-moma.png
url: https://raw.githubusercontent.com/api-evangelist/moma-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Precision Medicine
- Life Sciences
- Structural Biology
- Machine-Learning
- content-api
tags_raw:
- Company
- biotechnology
- pharmaceuticals
- drug-discovery
- oncology
- precision-medicine
- life-sciences
- structural-biology
- machine-learning
- content-api
apis:
- aid: moma-therapeutics:moma-therapeutics-posts-api
name: MOMA Therapeutics Content Posts API
description: News archive — company press releases, media coverage, peer-reviewed publications and conference presentations
(32 published at harvest time, spanning April 2020 through August 2026).
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Posts
tags_raw:
- posts
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-posts-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-posts-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-pages-api
name: MOMA Therapeutics Content Pages API
description: Corporate pages — Science, Pipeline, MOMA, Team, Join Us, News Feed, Privacy Policy and Terms (9 published
at harvest time). The acf.modules flexible-content array carries the page-builder blocks that compose each page.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Pages
tags_raw:
- pages
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-pages-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-pages-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-team-api
name: MOMA Therapeutics Team API
description: The team custom post type — leadership, board of directors, scientific advisory board and founders (59 published
records at harvest time), classified by the MOMA-specific team_types taxonomy and carrying each person's role in acf.member_title.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Team
tags_raw:
- team
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-team-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-team-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-media-api
name: MOMA Therapeutics Media API
description: Media library — AACR conference posters, publication PDFs, headshots, logos and site imagery (211 attachments
at harvest time).
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Media
tags_raw:
- media
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-media-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-media-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-taxonomy-api
name: MOMA Therapeutics Taxonomy API
description: Term collections for the three registered taxonomies — category (4 terms including Blog and Press Release),
post_tag (registered but empty) and the MOMA-specific team_types (3 terms including Founders).
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Taxonomy
tags_raw:
- taxonomy
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-taxonomy-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-taxonomy-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-discovery-api
name: MOMA Therapeutics Discovery API
description: Self-describing metadata — the 219-route index across 12 namespaces, plus registered post types, taxonomies
and statuses. This is the only machine-readable contract the company serves.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Discovery
tags_raw:
- discovery
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-discovery-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-discovery-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-search-api
name: MOMA Therapeutics Search API
description: Cross-content search over every published object — posts, pages and team records. An unfiltered query returned
42 results at harvest time.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Search
tags_raw:
- search
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-search-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-search-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-comments-api
name: MOMA Therapeutics Comments API
description: Comment collection. Registered and anonymously reachable, but empty — no object on this deployment carries
comments.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Comments
tags_raw:
- comments
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-comments-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-comments-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-oembed-api
name: MOMA Therapeutics oEmbed API
description: oEmbed 1.0 provider endpoint for momatx.com URLs, returning rich embeddable responses.
humanURL: https://developer.wordpress.org/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- oEmbed
tags_raw:
- oembed
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-oembed-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-oembed-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- aid: moma-therapeutics:moma-therapeutics-options-api
name: MOMA Therapeutics Site Options API
description: Advanced Custom Fields options-page payload, anonymously readable at /acf/v3/options/options. It carries site-wide
configuration — logo, footer contact block, social profile URLs, copyright line and visual-identity settings — with no
field-level access control.
humanURL: https://www.advancedcustomfields.com/resources/rest-api/
baseURL: https://momatx.com/wp-json
tags:
- Options
tags_raw:
- options
properties:
- type: OpenAPI
url: openapi/moma-therapeutics-options-api-openapi.yml
- type: Overlay
url: overlays/moma-therapeutics-options-api-overlay.yaml
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Website
url: https://momatx.com/
- type: About
url: https://momatx.com/moma/
- type: Science
url: https://momatx.com/science/
- type: Pipeline
url: https://momatx.com/pipeline/
- type: Team
url: https://momatx.com/team/
- type: News
url: https://momatx.com/news-feed/
- type: Blog
url: https://momatx.com/posts/category/blog/
- type: BlogRSS
url: https://momatx.com/feed/
- type: PressReleases
url: https://momatx.com/posts/category/press-release/
- type: Careers
url: https://momatx.com/join-us/
- type: PrivacyPolicy
url: https://momatx.com/privacy-policy/
- type: TermsOfService
url: https://momatx.com/terms/
- type: LinkedIn
url: https://www.linkedin.com/company/momatx
- type: Twitter
url: https://twitter.com/moma_tx
- type: YouTube
url: https://www.youtube.com/channel/UCqBg_d0f0IqXUDbzADjcI1g
- type: SecondaryMarket
url: https://forgeglobal.com/moma-therapeutics_stock/
- type: Authentication
url: authentication/moma-therapeutics-authentication.yml
- type: Conventions
url: conventions/moma-therapeutics-conventions.yml
- type: Conformance
url: conformance/moma-therapeutics-conformance.yml
- type: ErrorCatalog
url: errors/moma-therapeutics-problem-types.yml
- type: Lifecycle
url: lifecycle/moma-therapeutics-lifecycle.yml
- type: DataModel
url: data-model/moma-therapeutics-data-model.yml
- type: Packages
url: packages/moma-therapeutics-packages.yml
- type: DomainSecurity
url: security/moma-therapeutics-domain-security.yml
- type: RateLimits
url: rate-limits/moma-therapeutics-rate-limits.yml
- type: Plans
url: plans/moma-therapeutics-plans-pricing.yml
- type: LLMsTxt
url: llms/moma-therapeutics-llms.txt
- type: AgentSkill
url: skills/_index.yml
x-enrichment:
date: '2026-08-26'
status: enriched
artifacts_added: 38
pass: local-v1
Every provider here is available over the APIs.io API and to AI agents over MCP.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for providers
9 MCP tools reach this
find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.
All 92 tools →
Call it yourself
curl for this page
This provider
curl "https://apis.io/api/v1/providers/moma-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/moma-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/moma-therapeutics/evidence"
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no email required.
A second provider on the same verified email joins the account you already have.